Cannabics Pharmaceuticals Hires Two New Scientists to Further Develop Cannabinoid Diagnostic Tests and Treatments for Cancer

Cannabics Pharmaceuticals Hires Two New Scientists to Further Develop Cannabinoid Diagnostic Tests and Treatments for Cancer

May 22, 2018 Dr. Haleli Sharir and Dr. Nir Kfir bring expertise in cannabinoid research and high-content screening assessments TEL AVIV, Israel and BETHESDA, Maryland, May 22, 2018 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (CNBX), leader in cannabinoid diagnostic tests for personalized cancer treatment, announced today the